NCT05840211 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05838521 A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer Status RECRUITING Phase PHASE2
NCT05833867 Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE1
NCT05829434 Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS Status WITHDRAWN Phase PHASE2
NCT05814432 Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS Status RECRUITING Phase PHASE3
NCT05813964 Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France. Status RECRUITING Phase PHASE3
NCT05770895 Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B Status COMPLETED Phase PHASE1
NCT05765344 Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function Status COMPLETED Phase PHASE1
NCT05760300 A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function Status COMPLETED Phase PHASE1
NCT05729568 A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05718700 Study of Bulevirtide in Participants With Chronic Hepatitis D Infection Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05715528 Study of Obeldesivir in Nonhospitalized Participants With COVID-19 Status COMPLETED Phase PHASE3
NCT05690815 Express Testing and Same-day Initiation of PrEP Study Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05685810 Genetic Determinants of Kidney Disease in People of African Ancestry With HIV Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05676931 Study With Various Immunotherapy Treatments in Participants With Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2